International Conf on Alzheimer Disease and Related Disorders in the Middle East
International Conf on Alzheimer Disease and Related Disorders in the Middle East
批准号:
8528926
负责人:
CHANGIZ GEULA
金额:
$4.05万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-01 至 2014-03-31
关键词:
AddressAffectAgingAlzheimer&aposs DiseaseAmericasArabsAreaAttentionAwarenessBahrainBasic ScienceBehavioralBiotechnologyBrain DiseasesCanadaCaringClinical SciencesCollaborationsCommunicationCommunitiesConsanguinityCountryDementiaDiagnosisDietDisabled PersonsDiseaseEducationEgyptElderlyEnsureEpidemicEthicsEuropeFatty acid glycerol estersFeedbackFosteringFundingFutureGenerationsGoalsGovernmentHealthHuman ResourcesIndividualInternationalInvestigationIranIsraelJordanJournalsLeadLearningLebanonLinkLogisticsMedicalMeleagris gallopavoMiddle EastMilitary PersonnelMolecular GeneticsMuseumsNeurodegenerative DisordersNeurologyNorth AmericaNursesOralPalestinianParticipantPatientsPharmacologic SubstancePoliciesPopulationPopulation SizesPostdoctoral FellowPublic PolicyPublishingQatarRecording of previous eventsResearchResearch PersonnelSaudi ArabiaScientistSmokingSocial WorkersStudentsSuggestionSyriaTimeTunisiaUnited Arab EmiratesUniversitiesWest BankWomanWorkabstractingage groupagedauthoritybaseclinical Diagnosisexperiencefollower of religion Jewishgraduate studenthandicapping conditionimprovedlecturesmedical attentionmeetingsmild cognitive impairmentpostersprofessorprogramspublic health relevancesocialsuccesssymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alzheimer's disease is a major health problem and the leading cause of dementia in the Americas and Europe. There has been little work done on dementia in the Middle East. This is an important issue because of the progressive aging of the populations of the world, including the Middle East. For example, the size of the population of Egyptians 60 years and older is expected to increase by 316% from 2000 to 2030. Also, public awareness of dementia in the Middle East is low, and in many cases demented patients do not receive medical attention. The goal of this proposal is to obtain support for the Sixth International Conference on Alzheimer's Disease and Related Disorders in the Middle East. The objectives of this conference are to focus attention on neurodegenerative disorders of the aged, particularly Alzheimer's Disease, in the Middle East, to raise scientific, medical and social awareness of these disorders, and to enhance communication between Arab and Jewish medical and scientific personnel as well as communication between Middle Eastern workers and their counterparts in other countries, particularly the USA. It is anticipated that the meetin will lead to increased studies of dementia in the Middle East, a region with unique features valuable for research, including a high rate of consanguinity and smoking, relatively homogenous populations, and high fat diet. The primary organizers are from Middle Eastern background and are thoroughly familiar with the cultural traditions of the region, and along with the past organizer of these conferences, have built continuing collaborative relationships with works in the Middle East. A target audience of clinicians, scientists, nurses, social workers, government representatives and other agencies, pharmaceutical and other biotechnology companies will attend the meeting to be held in Istanbul, Turkey, March 23-24, 2013. Attendees will be from the majority of Middle Eastern countries including Bahrain, Egypt, Iran, Israel, Jordan, Lebanon, Palestinian Authority, Qatar, Saudi Arabia, Syria, Tunisia, Turkey, United Arab Emirates and the West Bank and will include will include workers from Europe, North America and other parts of the world. Topics to be covered include clinical and basic science aspects of dementia, diagnoses, history, management, treatment, and ethics, with consideration of the unique cultural traditions of Arab and Jewish populations. The organizers have successfully convened five editions of this conference in the past, and based on past experience expect an even more successful sixth conference.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease
-
批准号:10901316
-
项目类别:
-
资助金额:$74.79万
-
财政年份:2023
-
负责人:CHANGIZ GEULA
-
依托单位:
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
-
批准号:10276525
-
项目类别:
-
资助金额:$413.0万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Research Education Component
-
批准号:10469453
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Biospecimen/Neuropathology Core
-
批准号:10276530
-
项目类别:
-
资助金额:$56.31万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Biospecimen/Neuropathology Core
-
批准号:10687278
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Research Education Component
-
批准号:10264374
-
项目类别:
-
资助金额:$47.42万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Research Education Component
-
批准号:10662493
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
-
批准号:10687271
-
项目类别:
-
资助金额:$127.95万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease
-
批准号:10359727
-
项目类别:
-
资助金额:$75.18万
-
财政年份:2020
-
负责人:CHANGIZ GEULA
-
依托单位:
Characterized Adult Primary Human Microglia Cells for Research
-
批准号:10004183
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2018
-
负责人:CHANGIZ GEULA
-
依托单位:
Characterized Adult Primary Human Microglia Cells for Research
-
批准号:9788539
-
项目类别:
-
资助金额:$26.3万
-
财政年份:2018
-
负责人:CHANGIZ GEULA
-
依托单位:
Characterized Adult Primary Human Microglia Cells for Research
-
批准号:10248370
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2018
-
负责人:CHANGIZ GEULA
-
依托单位:
7th Intern Conf on AD and Related Disorders in the Middle East
-
批准号:9261277
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2016
-
负责人:CHANGIZ GEULA
-
依托单位:
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates
-
批准号:9918541
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:8896086
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates
-
批准号:9056631
-
项目类别:
-
资助金额:$46.73万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Generation of High Passage and Immortalized Human Microglia Cell Lines
-
批准号:8797358
-
项目类别:
-
资助金额:$20.1万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:9923902
-
项目类别:
-
资助金额:$68.56万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:10600105
-
项目类别:
-
资助金额:$66.79万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:9326361
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
海外基金